TRIFLUCAN Side Effects

7020828-1 | Caesarean Section, Foetal Arrhythmia
on Sep 23, 2010 Female patient from FRANCE , weighting 5.27 lb, was diagnosed with candidiasis and was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, foetal arrhythmia. Triflucan dosage: 3 Df, Weekly, On Thursay. During the same period patient was treated with THIOVALONE (1 Df, 3x/day) (View Thiovalone Review and Thiovalone Label ), TOPLEXIL (10 Ml, 2x/day) (View Toplexil Review and Toplexil Label ), OZOTHIN (1 Df, 1x/day) (View Ozothin Review and Ozothin Label ), RHINOFLUIMUCIL (1 Df, 3x/day) (View Rhinofluimucil Review and Rhinofluimucil Label ), PARACETAMOL (1 Df, 3x/day) (View Paracetamol Review and Paracetamol Label ).

7016310-8 | Caesarean Section, Foetal Arrhythmia
Patient was taking Triflucan (View Usage). Patient had the following side effects: caesarean section, foetal arrhythmia on Sep 15, 2010 from FRANCE Additional patient health information: Female patient , weighting 5.27 lb, was diagnosed with candidiasis and. Triflucan dosage: 3 Df, Weekly, On Thursay. During the same period patient was treated with THIOVALONE (1 Df, 3x/day) (View Thiovalone Review and Thiovalone Label ), TOPLEXIL (10 Ml, 2x/day) (View Toplexil Review and Toplexil Label ), OZOTHIN (1 Df, 1x/day) (View Ozothin Review and Ozothin Label ), RHINOFLUIMUCIL (1 Df, 3x/day) (View Rhinofluimucil Review and Rhinofluimucil Label ), PARACETAMOL (1 Df, 3x/day) (View Paracetamol Review and Paracetamol Label ).

7006121-1 | Pancytopenia
Adverse event was reported on Sep 09, 2010 by a Male patient taking Triflucan (View Usage) (Dosage: 100 Mg, 1x/day) was diagnosed with multiple myeloma (What is multiple myeloma?), atrial fibrillation (What is atrial fibrillation?), lung disorder and. Location: FRANCE , 72 years of age, After Triflucan was administered, patient had the following side effects: pancytopenia. During the same period patient was treated with REVLIMID (25 Mg, 1x/day, 3 Weeks Out Of 4) (View Revlimid Review and Revlimid Label ), CORDARONE (1 Df, 1x/day) (View Cordarone Review and Cordarone Label ), ROCEPHIN (1 G, 1x/day) (View Rocephin Review and Rocephin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ), ASPEGIC 1000 (250 Mg, 1x/day) (View Aspegic 1000 Review and Aspegic 1000 Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6927925-7 | Blood Creatinine Increased
on Aug 05, 2010 Male patient from FRANCE , 16 years of age, was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased. Triflucan dosage: 1 Df, 1x/day. During the same period patient was treated with PROGRAF (6 Mg, 2x/day) (View Prograf Review and Prograf Label ), CREON (View Creon Review and Creon Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CELLCEPT (Unk) (View Cellcept Review and Cellcept Label ), VALGANCICLOVIR (View Valganciclovir Review and Valganciclovir Label ), NEXIUM (View Nexium Review and Nexium Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), CORTANCYL (5 Mg, Unk) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.


6927806-9 | Bone Marrow Failure
on Aug 05, 2010 Male patient from FRANCE , 58 years of age, was diagnosed with herpes simplex serology positive, haemophilus infection and was treated with Triflucan (View Usage). Patient had the following side effects: bone marrow failure. Triflucan dosage: Unk. During the same period patient was treated with PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), PRIMPERAN TAB (Unk) (View Primperan Tab Review and Primperan Tab Label ), COLCHICINE OPALCIUM (Unk) (View Colchicine Opalcium Review and Colchicine Opalcium Label ), ZELITREX (Unk) (View Zelitrex Review and Zelitrex Label ), OFLOCET (Unk) (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

6895830-0 | Tendonitis
Patient was taking Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: tendonitis on Jul 22, 2010 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with oral fungal infection, lung infection and. Triflucan dosage: 2 Df, 1x/day. During the same period patient was treated with OFLOCET (2 Df, 1x/day) (View Oflocet Review and Oflocet Label ), AUGMENTIN '125' (3 Df, 1x/day) (View Augmentin '125' Review and Augmentin '125' Label ), TIAPRIDE (Unk) (View Tiapride Review and Tiapride Label ), ARIXTRA (1 Df, 1x/day) (View Arixtra Review and Arixtra Label ), PANTOPRAZOLE SODIUM (20 Mg, 1x/day) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), IMOVANE (View Imovane Review and Imovane Label ), SPECIAFOLDINE (Unk) (View Speciafoldine Review and Speciafoldine Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

6895390-4 | Anaemia, Coagulopathy, Effusion, Epistaxis, Gastrointestinal Stoma Complication, Haematochezia, Haemorrhage, Headache, Inflammation
Adverse event was reported on Jul 22, 2010 by a Male patient taking Triflucan (View Usage) (Dosage: 400 Mg After Dialysis) was diagnosed with candida sepsis, bacterial sepsis and. Location: FRANCE , 30 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, coagulopathy, effusion, epistaxis, gastrointestinal stoma complication, haematochezia, haemorrhage, headache (What is headache?), inflammation. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM (4 G, 2x/day) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), NEXIUM (40 Mg, 1x/day) (View Nexium Review and Nexium Label ), CACIT D3 (1 Df, 1x/day) (View Cacit D3 Review and Cacit D3 Label ), FUROSEMIDE (1500 Mg Daily Dose) (View Furosemide Review and Furosemide Label ), SOMATOSTATIN (Unk) (View Somatostatin Review and Somatostatin Label ), DIPEPTIVEN (View Dipeptiven Review and Dipeptiven Label ). Patient was hospitalized.

6886792-0 | Agranulocytosis, Febrile Neutropenia
on Jul 19, 2010 Male patient from FRANCE , 68 years of age, weighting 220.5 lb, was diagnosed with systemic candida, endocarditis (What is endocarditis?) and was treated with Triflucan (View Usage). Patient had the following side effects: agranulocytosis, febrile neutropenia. Triflucan dosage: 600 Mg, 1x/day. During the same period patient was treated with AMLOR (10 Mg, 1x/day) (View Amlor Review and Amlor Label ), PREVISCAN (1 Df, Per Day) (View Previscan Review and Previscan Label ), LASIX (60 Mg, 2x/day) (View Lasix Review and Lasix Label ), DUPHALAC (1 Df, 1x/day) (View Duphalac Review and Duphalac Label ), PANTOPRAZOLE SODIUM (20 Mg, 1x/day) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), DIFFU K (3 Intakes Per Day) (View Diffu K Review and Diffu K Label ), EUPRESSYL (60 Mg, 2x/day) (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

6870085-1 | Febrile Neutropenia
on Jul 13, 2010 Male patient from FRANCE , 68 years of age, weighting 220.5 lb, was diagnosed with systemic candida, endocarditis (What is endocarditis?) and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: febrile neutropenia. Triflucan dosage: 600 Mg, 1x/day. During the same period patient was treated with AMLOR (10 Mg, 1x/day) (View Amlor Review and Amlor Label ), PREVISCAN (1 Df, Per Day) (View Previscan Review and Previscan Label ), LASIX (60 Mg, 2x/day) (View Lasix Review and Lasix Label ), DUPHALAC (1 Df, 1x/day) (View Duphalac Review and Duphalac Label ), PANTOPRAZOLE SODIUM (20 Mg, 1x/day) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), DIFFU K (3 Intakes Per Day) (View Diffu K Review and Diffu K Label ), EUPRESSYL (60 Mg, 2x/day) (View Eupressyl Review and Eupressyl Label ). Patient was hospitalized.

6790303-8 | Epistaxis, Platelet Aggregation Abnormal, Wound Haemorrhage
Patient was taking Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, platelet aggregation abnormal, wound haemorrhage on Jun 15, 2010 from FRANCE Additional patient health information: Male patient , 30 years of age, was diagnosed with candida sepsis, bacterial sepsis and. Triflucan dosage: 400 Mg After Dialysis. During the same period patient was treated with TAZOCILLINE (1 Df, 2x/day) (View Tazocilline Review and Tazocilline Label ), NEXIUM (40 Mg, 1x/day) (View Nexium Review and Nexium Label ), CACIT D3 (1 Df, 1x/day) (View Cacit D3 Review and Cacit D3 Label ), FUROSEMIDE (1500 Mg Daily Dose) (View Furosemide Review and Furosemide Label ), SOMATOSTATIN (Unk) (View Somatostatin Review and Somatostatin Label ), DIPEPTIVEN (View Dipeptiven Review and Dipeptiven Label ). Patient was hospitalized.

6785997-7 | International Normalised Ratio Increased
Adverse event was reported on Jun 11, 2010 by a Male patient taking Triflucan (View Usage) (Dosage: ) . Location: FRANCE , 71 years of age, Patient had the following side effects: international normalised ratio increased. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6779442-5 | Depressed Level Of Consciousness, Dizziness, Encephalopathy, Overdose, Somnolence, Tremor
on Jun 09, 2010 Female patient from FRANCE , 60 years of age, was diagnosed with candida test positive, epilepsy (What is epilepsy?), endocarditis (What is endocarditis?) and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: depressed level of consciousness, dizziness (What is dizziness?), encephalopathy, overdose, somnolence, tremor. Triflucan dosage: 400 Mg, 1x/day. During the same period patient was treated with PHENYTOIN (Unk) (View Phenytoin Review and Phenytoin Label ), FORTUM (4 G, 1x/day) (View Fortum Review and Fortum Label ). Patient was hospitalized.

6764357-9 | Abdominal Wall Haematoma
on Jun 01, 2010 Male patient from FRANCE , 97 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal wall haematoma. Triflucan dosage: 50 Mg/day. During the same period patient was treated with ARIXTRA (1 Df/day) (View Arixtra Review and Arixtra Label ), KARDEGIC (75 Mg/day) (View Kardegic Review and Kardegic Label ), MYCOSTATIN (Unk) (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

6760677-2 | Anaemia, Neutropenia, Thrombocytopenia
Patient was taking Triflucan (View Usage). Patient had the following side effects: anaemia, neutropenia, thrombocytopenia on May 27, 2010 from FRANCE Additional patient health information: Female patient , 42 years of age, was diagnosed with oesophageal candidiasis, polymyositis, cytomegalovirus oesophagitis and. Triflucan dosage: 200 Mg, 1x/day. During the same period patient was treated with IMUREL (100 Mg, 1x/day) (View Imurel Review and Imurel Label ), CYMEVAN (Unk Mg, 2x/day) (View Cymevan Review and Cymevan Label ), VALGANCICLOVIR (900 Mg, 1x/day) (View Valganciclovir Review and Valganciclovir Label ), POSACONAZOLE (200 Mg Daily) (View Posaconazole Review and Posaconazole Label ), TEGELINE (View Tegeline Review and Tegeline Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6759234-3 | International Normalised Ratio Increased
Adverse event was reported on May 26, 2010 by a Male patient taking Triflucan (View Usage) (Dosage: 1 Df, 1x/day) was diagnosed with fungal infection (What is fungal infection?), lung disorder, thrombosis prophylaxis, chronic obstructive pulmonary disease, hypertension and. Location: FRANCE , 89 years of age, weighting 121.3 lb, After Triflucan was administered, patient had the following side effects: international normalised ratio increased. During the same period patient was treated with TAZOCILLINE (1 Df, 2x/day) (View Tazocilline Review and Tazocilline Label ), PREVISCAN (0.5 Df, Unk) (View Previscan Review and Previscan Label ), CIPROFLOXACIN (500 Mg, 1x/day) (View Ciprofloxacin Review and Ciprofloxacin Label ), SOLUPRED (20 Mg, 1x/day) (View Solupred Review and Solupred Label ), CEFTRIAXONE (1 G, 1x/day) (View Ceftriaxone Review and Ceftriaxone Label ), METRONIDAZOLE (1 Df, 3x/day) (View Metronidazole Review and Metronidazole Label ), TRIATEC (View Triatec Review and Triatec Label ).

6741337-0 | Cytolytic Hepatitis, Transaminases Increased
on May 17, 2010 Female patient from FRANCE , weighting 7.28 lb, was diagnosed with candidiasis, pyrexia, gastroenteritis rotavirus and was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, transaminases increased. Triflucan dosage: 30 Mg, 1x/day (loaded Dose). During the same period patient was treated with DOLIPRANE (40 Mg, 4x/day) (View Doliprane Review and Doliprane Label ), TIORFAN (10 Mg, 1x/day) (View Tiorfan Review and Tiorfan Label ). Patient was hospitalized.

6697165-8 | Haematoma, Haemorrhage, Thrombocytopenia
on Apr 14, 2010 Female patient from FRANCE , 58 years of age, was diagnosed with aortic valve replacement and was treated with Triflucan (View Usage). Patient had the following side effects: haematoma, haemorrhage, thrombocytopenia. Triflucan dosage: Unk. During the same period patient was treated with CYMEVAN (Unk) (View Cymevan Review and Cymevan Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), HEPARIN (Unk) (View Heparin Review and Heparin Label ). Patient was hospitalized.

6686981-4 | Thrombocytopenia
Patient was taking Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: thrombocytopenia on Apr 07, 2010 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with gastrooesophageal reflux disease, procedural pain, hypothyroidism, pancreatic insufficiency, depression (What is depression?) and. Triflucan dosage: 1 Df, 1x/day. During the same period patient was treated with NEXIUM (40 Mg, Unk) (View Nexium Review and Nexium Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), ERYTHROMYCIN (250 Mg, 3x/day) (View Erythromycin Review and Erythromycin Label ), LEVOTHYROX (150 Ug, 1x/day) (View Levothyrox Review and Levothyrox Label ), CREON (Unk) (View Creon Review and Creon Label ), IXEL (50 Mg, 3x/day) (View Ixel Review and Ixel Label ). Patient was hospitalized.

6673287-2 | Hepatic Encephalopathy
Adverse event was reported on Mar 29, 2010 by a Male patient taking Triflucan (View Usage) (Dosage: 400 Mg, 2x/day) was diagnosed with candidiasis, sciatica (What is sciatica?), sepsis (What is sepsis?) and. Location: FRANCE , 41 years of age, Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. During the same period patient was treated with NEURONTIN (200 Mg, 3x/day) (View Neurontin Review and Neurontin Label ), TAVANIC (750 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), DALACIN (600 Mg, 2x/day) (View Dalacin Review and Dalacin Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ). Patient was hospitalized.

6661487-7 | Thrombocytopenia
on Mar 23, 2010 Male patient from FRANCE , 52 years of age, was diagnosed with gastrooesophageal reflux disease, procedural pain, hypothyroidism, pancreatic insufficiency, depression (What is depression?) and was treated with Triflucan (View Usage). Patient had the following side effects: thrombocytopenia. Triflucan dosage: 1 Df, 1x/day. During the same period patient was treated with NEXIUM (40 Mg, Unk) (View Nexium Review and Nexium Label ), LOVENOX (Unk) (View Lovenox Review and Lovenox Label ), PARACETAMOL (PERFALGAN) (Unk) (View Paracetamol (perfalgan) Review and Paracetamol (perfalgan) Label ), ERYTHROMYCIN (250 Mg, 3x/day) (View Erythromycin Review and Erythromycin Label ), LEVOTHYROX (150 Ug, 1x/day) (View Levothyrox Review and Levothyrox Label ), CREON (Unk) (View Creon Review and Creon Label ), IXEL (50 Mg, 3x/day) (View Ixel Review and Ixel Label ). Patient was hospitalized.

6582802-9 | Stevens-johnson Syndrome
on Feb 08, 2010 Female patient from FRANCE , 25 years of age, weighting 121.3 lb, was diagnosed with genital infection female, acne (What is acne?) and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: stevens-johnson syndrome. Triflucan dosage: 50 Mg, 1x/day. During the same period patient was treated with ATARAX (25 Mg, 1x/day) (View Atarax Review and Atarax Label ), TOLEXINE (Unk) (View Tolexine Review and Tolexine Label ), ZELITREX (1 Df, 2x/day) (View Zelitrex Review and Zelitrex Label ), BETADINE GYNECOLOGICAL (View Betadine Gynecological Review and Betadine Gynecological Label ). Patient was hospitalized.

6568012-X | Pruritus, Rash Maculo-papular
Patient was taking Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash maculo-papular on Jan 22, 2010 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Triflucan dosage: 1 Df, 1x/day. During the same period patient was treated with PYOSTACINE (2 Df, 3x/day) (View Pyostacine Review and Pyostacine Label ), BRISTOPEN (1000 Mg, 2x/day) (View Bristopen Review and Bristopen Label ), DOMPERIDONE (Unk) (View Domperidone Review and Domperidone Label ), FUCIDINE (Unk) (View Fucidine Review and Fucidine Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), GAVISCON (Unk) (View Gaviscon Review and Gaviscon Label ), CELESTENE (Unk) (View Celestene Review and Celestene Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ). Patient was hospitalized.

6527266-6 | Blood Amylase Increased, Cholestasis, Lipase Increased, Rash Maculo-papular, Transaminases Increased
Adverse event was reported on Dec 28, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: Unk) . Location: FRANCE , 76 years of age, Patient had the following side effects: blood amylase increased, cholestasis, lipase increased, rash maculo-papular, transaminases increased. During the same period patient was treated with TAZOCILLINE (Unk) (View Tazocilline Review and Tazocilline Label ), CIFLOX (Unk) (View Ciflox Review and Ciflox Label ). Patient was hospitalized.

6527256-3 | Hypoprothrombinaemia
on Dec 28, 2009 Female patient from FRANCE , 86 years of age, was diagnosed with cardiovascular disorder, oesophageal candidiasis and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: hypoprothrombinaemia. Triflucan dosage: Unk. During the same period patient was treated with PREVISCAN (5 Mg, 1x/day) (View Previscan Review and Previscan Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ). Patient was hospitalized.

6526999-5 | Toxic Epidermal Necrolysis
on Dec 28, 2009 Female patient from FRANCE , 92 years of age, was diagnosed with oral candidiasis, hydrocholecystis and was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Triflucan dosage: Unk. During the same period patient was treated with AUGMENTIN (Unk) (View Augmentin Review and Augmentin Label ), ROCEPHIN (Unk) (View Rocephin Review and Rocephin Label ), INIPOMP (Unk) (View Inipomp Review and Inipomp Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ).

6503494-0 | Angioedema, Urticaria
Patient was taking Triflucan (View Usage). Patient had the following side effects: angioedema, urticaria on Dec 07, 2009 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Triflucan dosage: 50 Mg, 1x/day. During the same period patient was treated with MEDROL (16 Mg, 1x/day) (View Medrol Review and Medrol Label ), TAVANIC (500 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), SECTRAL (Unk) (View Sectral Review and Sectral Label ), CORTANCYL (Unk) (View Cortancyl Review and Cortancyl Label ), ARAVA (Unk) (View Arava Review and Arava Label ). Patient was hospitalized.

6500221-8 | Anaemia, Haematoma, International Normalised Ratio Increased
Adverse event was reported on Dec 04, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with erysipelas and. Location: FRANCE , 83 years of age, After Triflucan was administered, patient had the following side effects: anaemia, haematoma, international normalised ratio increased. During the same period patient was treated with PARACETAMOL (1 G, 4x/day) (View Paracetamol Review and Paracetamol Label ), PREVISCAN (15 Mg, 1x/day) (View Previscan Review and Previscan Label ), AUGMENTIN (1 G, 3x/day) (View Augmentin Review and Augmentin Label ). Patient was hospitalized.

6456997-1 | Anaemia, Haematoma, International Normalised Ratio Increased
on Nov 16, 2009 Female patient from FRANCE , 83 years of age, was diagnosed with erysipelas and was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma, international normalised ratio increased. Triflucan dosage: 50 Mg, 1x/day. During the same period patient was treated with PARACETAMOL (1 G, 4x/day) (View Paracetamol Review and Paracetamol Label ), PREVISCAN (15 Mg, 1x/day) (View Previscan Review and Previscan Label ), AUGMENTIN (1 G, 3x/day) (View Augmentin Review and Augmentin Label ). Patient was hospitalized.

6452765-5 | Cardio-respiratory Arrest, Torsade De Pointes
on Nov 12, 2009 Female patient from FRANCE , 30 years of age, was diagnosed with meningitis cryptococcal, hiv infection (What is hiv infection?), non-hodgkin's lymphoma and was treated with Triflucan (View Usage). Patient had the following side effects: cardio-respiratory arrest, torsade de pointes. Triflucan dosage: 200 Mg, 2x/day. During the same period patient was treated with ETRAVIRINE (1 Df, 2x/day) (View Etravirine Review and Etravirine Label ), TRUVADA (1 Df, 1x/day) (View Truvada Review and Truvada Label ), MABTHERA (Unk) (View Mabthera Review and Mabthera Label ), VINCRISTINE SULFATE (Unk) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HYDROCHLORIDE (Unk) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CANCIDAS (Unk) (View Cancidas Review and Cancidas Label ), NEULASTA (View Neulasta Review and Neulasta Label ).

6452758-8 | Overdose
Patient was taking Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: overdose on Nov 12, 2009 from FRANCE Additional patient health information: Female patient , 94 years of age, was diagnosed with depression (What is depression?), iron deficiency anaemia and. Triflucan dosage: Unk. During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ), ATHYMIL (30 Mg, 1x/day) (View Athymil Review and Athymil Label ), COVERSYL (Unk) (View Coversyl Review and Coversyl Label ), RISPERDAL (Unk) (View Risperdal Review and Risperdal Label ), TARDYFERON (Unk) (View Tardyferon Review and Tardyferon Label ), TRANXENE (Unk) (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

6434491-1 | Cardio-respiratory Arrest, Torsade De Pointes
Adverse event was reported on Oct 29, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: 200 Mg, 2x/day) was diagnosed with meningitis cryptococcal, hiv infection (What is hiv infection?), non-hodgkin's lymphoma and. Location: FRANCE , 30 years of age, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, torsade de pointes. During the same period patient was treated with ETRAVIRINE (1 Df, 2x/day) (View Etravirine Review and Etravirine Label ), TRUVADA (1 Df, 1x/day) (View Truvada Review and Truvada Label ), MABTHERA (Unk) (View Mabthera Review and Mabthera Label ), VINCRISTINE SULFATE (Unk) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HYDROCHLORIDE (Unk) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), CANCIDAS (Unk) (View Cancidas Review and Cancidas Label ), NEULASTA (View Neulasta Review and Neulasta Label ).

6415793-1 | Encephalopathy
on Oct 15, 2009 Female patient from FRANCE , 44 years of age, was diagnosed with oral fungal infection and was treated with Triflucan (View Usage). Patient had the following side effects: encephalopathy. Triflucan dosage: 200 Mg, 2x/day. During the same period patient was treated with CONTRAMAL (100 Mg, 2x/day) (View Contramal Review and Contramal Label ), LYRICA (View Lyrica Review and Lyrica Label ), KEPPRA (View Keppra Review and Keppra Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), KERLONE (View Kerlone Review and Kerlone Label ), NEXIUM (View Nexium Review and Nexium Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), NEULEPTIL (View Neuleptil Review and Neuleptil Label ). Patient was hospitalized.

6408262-6 | Extrasystoles
on Oct 09, 2009 Female patient from FRANCE , 40 years of age, was diagnosed with oral candidiasis and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: extrasystoles. Triflucan dosage: 50 Mg, 1x/day.

6405056-2 | Subdural Haematoma
Patient was taking Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: subdural haematoma on Oct 07, 2009 from FRANCE Additional patient health information: Female patient , 84 years of age, . Triflucan dosage: 50 Mg, 2x/day. During the same period patient was treated with PREVISCAN (10 Mg, 1x/day) (View Previscan Review and Previscan Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), HYDROCORTISONE (5 Mg, 1x/day) (View Hydrocortisone Review and Hydrocortisone Label ), FENOFIBRATE (Unk) (View Fenofibrate Review and Fenofibrate Label ), DEPAKENE (View Depakene Review and Depakene Label ), NEXIUM (View Nexium Review and Nexium Label ), ADANCOR (View Adancor Review and Adancor Label ).

6376548-X | Sinus Bradycardia
Adverse event was reported on Sep 15, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: 200 Mg, 2x/day) was diagnosed with acute myeloid leukaemia and. Location: FRANCE , 62 years of age, Patient had the following side effects: sinus bradycardia. During the same period patient was treated with VESANOID (Unk Mg, 2x/day) (View Vesanoid Review and Vesanoid Label ), CYTARABINE (200 Mg/m2, 1x/day) (View Cytarabine Review and Cytarabine Label ), IDARUBICIN (12 Mg/m2, Alternate Day D1, D3, D5) (View Idarubicin Review and Idarubicin Label ), DEXAMETHASONE (10 Mg, 2x/day) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6348875-3 | Bone Marrow Failure
on Sep 01, 2009 Female patient from FRANCE , 75 years of age, was diagnosed with skin candida, infection (What is infection?), candidiasis, analgesia and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: bone marrow failure. Triflucan dosage: 100 Mg, 1x/day. During the same period patient was treated with TIENAM (500 Mg, 4x/day) (View Tienam Review and Tienam Label ), LASIX (20 Mg, 2x/day) (View Lasix Review and Lasix Label ), VANCOMYCIN (2.5 G, 1x/day) (View Vancomycin Review and Vancomycin Label ), PEVARYL (Unk) (View Pevaryl Review and Pevaryl Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LYRICA (Unk) (View Lyrica Review and Lyrica Label ), TOPALGIC (Unk) (View Topalgic Review and Topalgic Label ). Patient was hospitalized.

6341478-6 | Cholestasis, Pancreatitis Acute
on Aug 24, 2009 Female patient from FRANCE , 22 years of age, was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, pancreatitis acute. Triflucan dosage: 400 Mg, 1x/day. During the same period patient was treated with KIDROLASE (9000 Iu, On 18sep, 20sep, 22 Sep, 30 Sep And 02oct) (View Kidrolase Review and Kidrolase Label ), GLEEVEC (400 Mg, 1x/day) (View Gleevec Review and Gleevec Label ), FLAGYL (500 Mg, 3x/day) (View Flagyl Review and Flagyl Label ), TAZOCILLINE (4 G, 3x/day) (View Tazocilline Review and Tazocilline Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), ACLOTINE (Unk) (View Aclotine Review and Aclotine Label ), XANAX (View Xanax Review and Xanax Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ). Patient was hospitalized.

6336667-0 | Haematuria, International Normalised Ratio Increased
Patient was taking Triflucan (View Usage). Patient had the following side effects: haematuria, international normalised ratio increased on Aug 20, 2009 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with candidiasis and. Triflucan dosage: 100 Mg, 1x/day. During the same period patient was treated with PREVISCAN (20 Mg, 1x/day) (View Previscan Review and Previscan Label ), TAHOR (View Tahor Review and Tahor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), GARDENAL ^AVENTIS^ (View Gardenal ^aventis^ Review and Gardenal ^aventis^ Label ), COVERSYL (View Coversyl Review and Coversyl Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), NOVONORM (View Novonorm Review and Novonorm Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6336247-7 | Toxic Skin Eruption
Adverse event was reported on Aug 20, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: Unk) was diagnosed with fungal infection (What is fungal infection?) and. Location: FRANCE , 81 years of age, After Triflucan was administered, patient had the following side effects: toxic skin eruption. During the same period patient was treated with AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), PREVISCAN (Unk) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6313107-9 | Cholestasis, Pancreatitis Acute
on Aug 06, 2009 Female patient from FRANCE , 22 years of age, was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, pancreatitis acute. Triflucan dosage: 400 Mg, 1x/day. During the same period patient was treated with KIDROLASE (9000 Iu, On 18sep, 20sep, 22 Sep, 30 Sep And 02oct) (View Kidrolase Review and Kidrolase Label ), GLEEVEC (400 Mg, 1x/day) (View Gleevec Review and Gleevec Label ), FLAGYL (500 Mg, 3x/day) (View Flagyl Review and Flagyl Label ), TAZOCILLINE (4 G, 3x/day) (View Tazocilline Review and Tazocilline Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), ACLOTINE (Unk) (View Aclotine Review and Aclotine Label ), XANAX (View Xanax Review and Xanax Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ). Patient was hospitalized.

6306861-3 | International Normalised Ratio Increased
on Jul 31, 2009 Female patient from FRANCE , 75 years of age, was diagnosed with fungal infection (What is fungal infection?), deep vein thrombosis (What is deep vein thrombosis?), thrombosis prophylaxis, sepsis (What is sepsis?) and was treated with Triflucan (View Usage). Patient had the following side effects: international normalised ratio increased. Triflucan dosage: 400 Mg, Unk. During the same period patient was treated with COUMADIN (3 Mg, 1x/day) (View Coumadin Review and Coumadin Label ), OFLOXACIN (400 Mg, Unk) (View Ofloxacin Review and Ofloxacin Label ), LANSOYL (View Lansoyl Review and Lansoyl Label ), APROVEL (View Aprovel Review and Aprovel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LYRICA (View Lyrica Review and Lyrica Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6303422-7 | Agitation, Hypoglycaemia
Patient was taking Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: agitation, hypoglycaemia on Jul 29, 2009 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with oral fungal infection and. Triflucan dosage: 100 Mg, 2x/day. During the same period patient was treated with AMAREL (4 Mg, 1x/day) (View Amarel Review and Amarel Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), COKENZEN (View Cokenzen Review and Cokenzen Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6302308-1 | Cholestasis, Pancreatitis Acute
Adverse event was reported on Jul 29, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: 400 Mg, 1x/day) . Location: FRANCE , 22 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, pancreatitis acute. During the same period patient was treated with KIDROLASE (9000 Iu, On 18sep, 20sep, 22 Sep, 30 Sep And 02oct) (View Kidrolase Review and Kidrolase Label ), GLEEVEC (400 Mg, 1x/day) (View Gleevec Review and Gleevec Label ), FLAGYL (500 Mg, 3x/day) (View Flagyl Review and Flagyl Label ), TAZOCILLINE (4 G, 3x/day) (View Tazocilline Review and Tazocilline Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), ACLOTINE (Unk) (View Aclotine Review and Aclotine Label ), XANAX (View Xanax Review and Xanax Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ). Patient was hospitalized.

6285141-9 | Cardio-respiratory Arrest, Hypokalaemia, Torsade De Pointes
on Jul 15, 2009 Female patient from FRANCE , 25 years of age, was treated with Triflucan (View Usage). Patient had the following side effects: cardio-respiratory arrest, hypokalaemia, torsade de pointes. Triflucan dosage: 400 Mg, 2x/day. During the same period patient was treated with CORDARONE (400 Mg, 1x/day) (View Cordarone Review and Cordarone Label ), CARDENSIEL (7500 Ug, 1x/day) (View Cardensiel Review and Cardensiel Label ), AMBISOME (120 Mg, 1x/day) (View Ambisome Review and Ambisome Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), SUBUTEX (0.4 Mg, 2x/day) (View Subutex Review and Subutex Label ), NICOTINE (1 Df, 1x/day In The Evening) (View Nicotine Review and Nicotine Label ), HEPARIN (0.4 Ml, 2x/day) (View Heparin Review and Heparin Label ), NEXIUM (200 Mg, 1x/day) (View Nexium Review and Nexium Label ).

6271803-6 | Clostridium Difficile Colitis
on Jul 07, 2009 Female patient from FRANCE , 60 years of age, was diagnosed with candidiasis and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: clostridium difficile colitis. Triflucan dosage: Unk. During the same period patient was treated with CEFTRIAXONE (1 G, 1x/day) (View Ceftriaxone Review and Ceftriaxone Label ), TAVANIC (1 G, 1x/day) (View Tavanic Review and Tavanic Label ), DIFFU K (View Diffu K Review and Diffu K Label ), CACIT (View Cacit Review and Cacit Label ), KARDEGIC (75 Mg, Unk) (View Kardegic Review and Kardegic Label ), SEGLOR (5 Mg, Unk) (View Seglor Review and Seglor Label ), PLAVIX (75 Mg, Unk) (View Plavix Review and Plavix Label ), SERESTA (50 Mg, Unk) (View Seresta Review and Seresta Label ). Patient was hospitalized.

6268525-4 | Haematoma, Prothrombin Time Shortened
Patient was taking Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, prothrombin time shortened on Jul 03, 2009 from FRANCE Additional patient health information: Female patient , 93 years of age, was diagnosed with candidiasis and. Triflucan dosage: 100 Mg, 2x/day. During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ). Patient was hospitalized.

6258477-5 | Abdominal Wall Haematoma, Accidental Overdose, Anaemia, International Normalised Ratio Increased
Adverse event was reported on Jul 06, 2009 by a Female patient taking Triflucan (View Usage) (Dosage: 50 Mg, 2x/day) was diagnosed with oral candidiasis, atrial fibrillation (What is atrial fibrillation?), urinary tract infection (What is urinary tract infection?), insomnia, anxiety (What is anxiety?), depression (What is depression?), osteoporosis (What is osteoporosis?) and. Location: FRANCE , 91 years of age, Patient had the following side effects: abdominal wall haematoma, accidental overdose, anaemia, international normalised ratio increased. During the same period patient was treated with PREVISCAN (0.25 Mg, 1x/day) (View Previscan Review and Previscan Label ), BACTRIM DS (1 Df, 2x/day) (View Bactrim Ds Review and Bactrim Ds Label ), FLECAINIDE ACETATE (100 Mg, 2x/day) (View Flecainide Acetate Review and Flecainide Acetate Label ), THERALENE (20 Gtt, 1x/day) (View Theralene Review and Theralene Label ), TEMESTA (2.5 Mg, 1x/day) (View Temesta Review and Temesta Label ), STABLON (12.5 Mg, 2x/day) (View Stablon Review and Stablon Label ), OROCAL (500 Mg, 2x/day) (View Orocal Review and Orocal Label ). Patient was hospitalized.

6258403-9 | Hyperthermia, Leukopenia, Neutropenia
on Jun 25, 2009 Female patient from FRANCE , 51 years of age, was diagnosed with tooth abscess, skin lesion and was treated with Triflucan (View Usage). After Triflucan was administered, patient had the following side effects: hyperthermia, leukopenia, neutropenia. Triflucan dosage: Unk. During the same period patient was treated with BIRODOGYL (2 Df, 2x/day) (View Birodogyl Review and Birodogyl Label ), AUGMENTIN (1 G, 3x/day) (View Augmentin Review and Augmentin Label ), FUCIDINE CAP (1 Df, 1x/day) (View Fucidine Cap Review and Fucidine Cap Label ), LACTEOL (Unk) (View Lacteol Review and Lacteol Label ), ULTRA LEVURE (50 Mg, Unk) (View Ultra-levure Review and Ultra-levure Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), FIV ASA (View Fiv-asa Review and Fiv-asa Label ). Patient was hospitalized.

6255852-X | Eczema, Eosinophilia, Toxic Skin Eruption, Vascular Purpura
on Jun 10, 2009 Female patient from FRANCE , 77 years of age, was treated with Triflucan (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), eosinophilia, toxic skin eruption, vascular purpura. Triflucan dosage: Unk. Patient was hospitalized.

6235796-X | International Normalised Ratio Increased
Patient was taking Triflucan (View Usage). Patient had the following side effects: international normalised ratio increased on Jun 08, 2009 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with fungal infection (What is fungal infection?), deep vein thrombosis (What is deep vein thrombosis?), thrombosis prophylaxis, sepsis (What is sepsis?) and. Triflucan dosage: 400 Mg, Unk. During the same period patient was treated with COUMADIN (3 Mg, 1x/day) (View Coumadin Review and Coumadin Label ), OFLOCET (400 Mg, Unk) (View Oflocet Review and Oflocet Label ), LANSOYL (View Lansoyl Review and Lansoyl Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LYRICA (View Lyrica Review and Lyrica Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.